Literature DB >> 323025

Physostigmine analgesia and somatosensory evoked responses in man.

N Sitaram, M S Buchsbaum, J C Gillin.   

Abstract

14 normal volunteers were given 0.5 mg physostigmine or saline placebo i.v. in a randomized double blind trial. Subjects were pretreated with 0.5 mg methscopolamine i.m. on both days. Pain ratings and average evoked responses were obtained to brief electrical stimuli administered to the forearm. Pain response criterion was significantly higher on physostigmine than on placebo. Average evoked response component P100 was significantly smaller on physostigmine than placebo, especially for higher intensity stimuli. These results are consistent with central cholinergic modulation of pain and arousal systems in man.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 323025     DOI: 10.1016/0014-2999(77)90295-3

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  3 in total

1.  Effects of morphine, physostigmine and raphe nuclei stimulation on 5-hydroxytryptamine release from the cerebral cortex of the cat.

Authors:  P Aiello-Malmberg; A Bartolini; R Bartolini; A Galli
Journal:  Br J Pharmacol       Date:  1979-04       Impact factor: 8.739

2.  The clinical assessment of analgesic drugs.

Authors:  D W Littlejohns; D W Vere
Journal:  Br J Clin Pharmacol       Date:  1981-04       Impact factor: 4.335

3.  Pain enhances naloxone-induced hyperalgesia in humans as assessed by somatosensory evoked potentials.

Authors:  M S Buchsbaum; G C Davis; D Naber; D Pickar
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.